title: Disease 'activity', 'severity' and 'impact': interrelationships in COPD; is a measure of disease 'activity' the Holy Grail for COPD, or a variable impossible to quantify?
abstract: It is increasingly recognised that new measures of disease 'activity' for COPD are required, however the relationship between markers of disease 'activity', 'severity' and 'impact' though closely linked, is poorly understood. Additionally, while change in markers of disease 'severity' (e.g. change in FEV1) may be considered a marker of disease 'activity', these quantify a single aspect of disease 'activity' in COPD rather than measuring the overall disease process and this has stimulated the search for new biomarkers of COPD that reflect the 'activity' of the disease process. The ideal biomarker of disease 'activity' would be stable with respect to time since measurement at any time point would then relate to subsequent disease progression. This would allow the influence of a therapeutic intervention to be assessed early, facilitating both phase 2 and 3 clinical trials. Although a number of potential biomarkers of COPD disease 'activity' have been studied, to date none have been shown to conclusively relate to disease progression and the stability of underlying disease 'activity' therefore requires further consideration. Interestingly, while the variability of disease 'activity' of COPD is rarely mentioned in the current literature, and there is uncertainty whether 'activity' is constant or highly variable, there are clues from available data as discussed in the current article. Finally we consider how markers of disease 'activity', 'severity' and 'impact' may relate, which is of utmost importance in the ongoing search for new biomarkers in COPD and a greater understanding of the pathogenesis of the disease process.
authors.affiliation: 1Centre for Translational Inflammation Research, University of Birmingham Research Laboratories , Birmingham , United Kingdom.
authors.forename: Richard I
authors.initials: RI
authors.lastname: Carter
authors.forename: Robert A
authors.initials: RA
authors.lastname: Stockley
mesh_terms: D015415:Biomarkers / Q000097:blood; D018450:Disease Progression; D006801:Humans; D029424:Pulmonary Disease, Chronic Obstructive / Q000503:physiopathology*; D012720:Severity of Illness Index
chemical_list: D015415:Biomarkers
keywords: COPD; activity; biological markers; severity